Emergency Department Management of Elevated Intraocular Pressure
In the emergency department, immediately measure IOP using applanation tonometry (or Tono-Pen if unavailable), perform focused slit-lamp examination and gonioscopy to identify angle-closure, and initiate aggressive medical therapy if IOP is markedly elevated, followed by urgent ophthalmology consultation for definitive laser iridotomy. 1
Initial Evaluation Components
Critical Measurements
- IOP measurement: Use Goldmann applanation tonometry as the gold standard 1. ED measurements have 78% sensitivity and 84% specificity for detecting IOP >25 mmHg 2
- Gonioscopy: Essential in all suspected angle-closure cases to evaluate angle anatomy, iridocorneal contact (ITC), and peripheral anterior synechiae (PAS) 1
- Visual acuity: Document baseline vision (ED measurements show 88% sensitivity for detecting VA worse than 20/40) 2
Key Physical Findings to Assess
- Pupil: Mid-dilated, asymmetric, or oval shape with poor reactivity suggests acute angle-closure crisis (AACC) 1
- Cornea: Microcystic and stromal edema common in acute cases; use topical glycerin to clear for better gonioscopic view 1
- Anterior chamber: Assess depth centrally and peripherally—shallow chambers indicate higher risk 1
- Conjunctiva: Hyperemia in acute presentations 1
- Lens: Look for glaukomflecken (anterior subcapsular opacities indicating prior attacks) 1
Gonioscopy Technique Pearls
Perform in a dark room with a bright, short (~1mm) beam that doesn't pass through the pupil to avoid pupillary constriction. Wait 10 seconds after lens placement to allow pupil to resume resting state. Use compression gonioscopy to distinguish appositional from synechial closure 1.
Immediate Medical Management for AACC
Initiate combination therapy immediately to rapidly lower IOP and relieve symptoms 1:
First-Line Agents (use multiple simultaneously)
- Topical beta-blockers (e.g., timolol)
- Topical alpha-2 agonists (e.g., brimonidine)
- Topical/oral/IV carbonic anhydrase inhibitors (e.g., acetazolamide)
- Topical parasympathomimetics (e.g., pilocarpine)
- Oral/IV hyperosmotic agents for rapid IOP reduction
Important Caveats
- Aqueous suppressants may be initially ineffective if ciliary body is ischemic from markedly elevated pressure 1
- Miotics may fail when IOP is extremely high due to pressure-induced sphincter ischemia 1
- Avoid parasympathomimetics in secondary pupillary block from gas, oil, vitreous, or lens—use mydriatics instead 1
Mechanical Maneuvers
Corneal indentation with four-mirror gonioscopy lens, cotton-tipped applicator, or muscle hook tip may help break pupillary block 1.
Definitive Treatment Pathway
Laser peripheral iridotomy (LPI) is the preferred definitive treatment and should be performed as soon as IOP is controlled and cornea clears 1. This:
- Relieves pupillary block by allowing aqueous to bypass the pupil
- Eliminates pressure gradient between posterior and anterior chambers
- Prevents or retards PAS formation
- Results in significant angle widening
If LPI Cannot Be Performed
When corneal edema or iris congestion prevents laser treatment 1:
- Clear cornea with topical hyperosmotic agents
- Consider anterior chamber paracentesis
- Perform laser iridoplasty
- If medical therapy fails to break attack: incisional iridectomy with possible concurrent filtering surgery if extensive PAS present
Alternative Approaches
Primary phacoemulsification and cyclophotocoagulation are options for AACC unresponsive to conventional treatment 1.
Disposition and Follow-up
All patients with elevated IOP concerning for angle-closure require same-day ophthalmology consultation 1. The ophthalmologist will:
- Perform definitive LPI once attack is broken
- Treat fellow eye prophylactically (high risk of bilateral disease)
- Determine need for chronic IOP-lowering therapy if residual trabecular meshwork damage present
Common Pitfall
Do not delay ophthalmology consultation waiting for "perfect" IOP control—timely definitive treatment prevents irreversible damage to optic nerve, trabecular meshwork, iris, lens, and cornea 1.